FORGOTTEN HISTORY: 6 | History Defined

Mounjaro manufacturer blasts UK as ‘worst country in Europe’ for drug prices

The boss of Eli Lilly, Dave Ricks, warns that Britain will miss out on new drugs as a result of pricing issues

The Independent UK · Sep 24, 2025

FDA Clears Merck's One-Minute Cancer Shot

The U.S. Food and Drug Administration (FDA) on Friday approved Merck Co. Inc.’s (NYSE:MRK) Keytruda Qlex (pembrolizumab and berahyaluronidase alfa-pmph) injection for subcutaneous administration in adults across most solid tumor indications for Keytruda.

Benzinga · Sep 22, 2025

Merck Scores Positive Feedback From EU Agency Regarding Blockbuster Cancer Drug

On Friday, a European agency adopted two positive opinions for Merck Co. Inc.’s (NYSE:MRK) Keytruda (pembrolizumab).

Benzinga · Sep 19, 2025

Merck's Exit Highlights UK Risks Losing Pharma Investment Amid Rising Costs

The U.K. faces a growing risk of losing pharmaceutical investment. That’s according to Oxford professor John Bell, a scientist who was involved in coordinating government and industry efforts during the COVID-19 vaccine rollout.

Benzinga · Sep 12, 2025

UK must heed Sir John Bell’s big pharma investment warning

Instead of making silly statements the government needs to look at why Merck has scrapped its £1bn research centre

The Guardian - UK · Sep 11, 2025

Merck Advances Childhood Pneumococcal Care With Promising Vaccine Data

Merck Co. Inc. (NYSE:MRK) on Thursday released results from the Phase 3 STRIDE-13 trial evaluating Capvaxive (Pneumococcal 21-valent Conjugate Vaccine) at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Conference.

Benzinga · Sep 11, 2025

Merck scraps 125 jobs as it cans £1bn London research hub

IN FULL

The Independent UK · Sep 11, 2025

Scientists analysed pesticide use across Europe. Here’s what they found

Increased demand for food due to population growth has made pesticides essential for ensuring food security

The Independent UK · Sep 11, 2025

Merck’s move to axe £1bn UK expansion was ‘commercial decision’, says minister

The Conservatives said Merck’s decision should send alarm bells ringing across Government.

Evening Standard · Sep 11, 2025

Pharma giant ditches £1bn London research hub and says UK ‘is not internationally competitive’

Merck, known as MSD in Europe, criticised the UK’s business environment despite the government saying it has become ‘the most attractive place to invest in the world’

The Independent UK · Sep 11, 2025